Statins modulate and modify ACE2 levels and produce epigenetic modifications, thereby preventing the progression to Acute Respiratory Distress Syndrome (ARDS) and also limit the severity of COVID-19, as shown in COVID-19 literature studies (Castiglione et al., 2020; Pawlos et al., 2021). The gene discussed is ACE2; the disease is acute respiratory distress syndrome.